(Q34022885)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972430%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

The evidence-based approach in health policy and health care delivery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972430%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972430%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

E W Grijseels

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972430%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

F F Rutten

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972430%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972430%20AND%20SRC:MED&resulttype=core&format=json

Social Science and Medicine

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972430%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972430%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972430%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

859-869

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972430%20AND%20SRC:MED&resulttype=core&format=json

Sensitivity analysis in economic evaluation: a review of published studies

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Environment and health

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Economic evaluation in support of national health policy: the case of The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Clinical guidelines: using clinical guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Toward consistency in cost-utility analyses: using national measures to create condition-specific values

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

The relation between funding by the National Institutes of Health and the burden of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Avoidable burden of illness: how much can prevention contribute to health?

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

A short history of INAHTA. International Network of Agencies for Health Technology Assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Clinical guidelines-the hidden costs

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

A systematic review of cost-effectiveness research of stroke evaluation and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

The impact of health economics on health policy in England, and the impact of health policy on health economics, 1972-1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Legal and political considerations of clinical practice guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Inequality in income and mortality in the United States: analysis of mortality and potential pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

The journal's policy on cost-effectiveness analyses.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Evaluation and management guidelines--fatally flawed

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

A vision of social justice as the foundation of public health: commemorating 150 years of the spirit of 1848

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

The November 1995 revised Australian guidelines for the economic evaluation of pharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Health impact assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Health care expenditure and mortality from amenable conditions in the European Community

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

How should interventions to reduce inequalities in health be evaluated?

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

A framework for incorporating cost-effectiveness in evidence-based clinical practice guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Econometric analyses of national health expenditures: can positive economics help to answer normative questions?

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Toward an analytical approach to health sector reform

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Assessing uncertainty in cost-effectiveness analyses: application to a complex decision model.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Programme budgeting and marginal analysis: an approach to priority setting in need of refinement

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Are we ready to use cost-effectiveness analysis in health care decision-making? A health services research challenge for clinicians, patients, health care systems, and public policy

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

The changing relation between mortality and level of economic development

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Evidence-based policy: rhetoric and reality

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Setting the stage for health impact assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Who should determine when health care is medically necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Economic evaluation and health care decision-making.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Evidence based medicine: what it is and what it isn't

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Health impact assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Clinical guidelines: developing guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

The impact of cost-effectiveness on public and private policies in health care: an international perspective. Introduction and overview

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

NICE: a panacea for the NHS?

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Who should decide? Qualitative analysis of panel data from public, patients, healthcare professionals, and insurers on priorities in health care

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

The measurement iterative loop: A framework for the critical appraisal of need, benefits and costs of health interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

The cost-effectiveness of breast cancer screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

The redistributive effect of health care finance in twelve OECD countries.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Heart transplantation in the Netherlands; costs, effects and scenarios

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Health status and medical expenditures: more evidence of a link

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2800%2900066-6

7 January 2021

10.1016/S0277-9536(00)00066-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972430%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference